Schroder Investment Management Group Dexcom Inc Transaction History

Schroder Investment Management Group

$122 Billion
Q3 2025

A detailed history of Schroder Investment Management Group transactions in Dexcom Inc stock. As of the latest transaction made, Schroder Investment Management Group holds 149,606 shares of DXCM stock, worth $8.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

149,606

Previous 39,931 274.66%

Holding current value

$8.69 Million

Previous $3.49 Million 188.84%

% of portfolio

0.01%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$66.46 - $89.53 $7.29 Million - $9.82 Million	109,675 Added 274.66%	149,606 $10.1 Million
Q2 2025 Aug 13, 2025	SELL	$59.83 - $87.57 $128,754 - $188,450	-2,152 Reduced 5.11%	39,931 $3.49 Million
Q1 2025 May 13, 2025	SELL	$67.74 - $90.75 $496,872 - $665,651	-7,335 Reduced 14.84%	42,083 $2.87 Million
Q4 2024 Feb 12, 2025	SELL	$65.68 - $81.01 $5.65 Million - $6.97 Million	-86,092 Reduced 63.53%	49,418 $3.84 Million
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $7.49 Million - $13.6 Million	-117,094 Reduced 46.35%	135,510 $9.08 Million
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $4.9 Million - $6.24 Million	44,435 Added 21.35%	252,604 $28.6 Million
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $2.92 Million - $3.58 Million	25,529 Added 13.98%	208,169 $28.9 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $78.1 Million - $128 Million	-1,034,562 Reduced 85.0%	182,640 $22.7 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $2.53 Million - $4.05 Million	-29,394 Reduced 2.36%	1,217,202 $114 Million
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $38.1 Million - $44.3 Million	-338,482 Reduced 21.35%	1,246,596 $160 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $2.66 Million - $3.14 Million	25,557 Added 1.64%	1,585,078 $184 Million
Q4 2022 Feb 10, 2023	SELL	$84.98 - $122.67 $7.48 Million - $10.8 Million	-88,037 Reduced 5.34%	1,559,521 $177 Million
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $9.2 Million - $11.4 Million	120,534 Added 7.89%	1,647,558 $133 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $79.4 Million - $155 Million	1,167,255 Added 324.45%	1,527,024 $114 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $2.16 Million - $2.99 Million	22,973 Added 6.82%	359,769 $187 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $7.08 Million - $8.88 Million	54,530 Added 19.32%	336,796 $181 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $1.07 Million - $1.44 Million	-10,072 Reduced 3.45%	282,266 $154 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $9.52 Million - $12.7 Million	117,531 Added 67.23%	292,338 $125 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $4.32 Million - $5.33 Million	50,923 Added 41.11%	174,807 $62.8 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $5.21 Million - $6.98 Million	66,815 Added 117.08%	123,884 $45.8 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $3.17 Million - $3.75 Million	33,166 Added 138.75%	57,069 $21.9 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $328,819 - $552,613	5,246 Added 28.12%	23,903 $9.69 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $847,746 - $1.34 Million	17,739 Added 1932.35%	18,657 $5.02 Million
Q4 2019 Feb 11, 2020	BUY	$36.62 - $57.29 $12,926 - $20,223	353 Added 62.48%	918 $201,000
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $13.6 Million - $16.8 Million	-383,752 Reduced 99.85%	565 $84,000
Q2 2018 Aug 13, 2018	SELL	$17.54 - $25.22 $7.66 Million - $11 Million	-436,659 Reduced 53.19%	384,317 $20 Million
Q1 2018 May 11, 2018	SELL	$13.06 - $18.54 $166,854 - $236,867	-12,776 Reduced 1.53%	820,976 $60.9 Million
Q4 2017 Feb 09, 2018	BUY	$11.12 - $15.38 $9.27 Million - $12.8 Million	833,752	833,752 $47.8 Million

Others Institutions Holding DXCM

# of Institutions

1,086

Shares Held

358M

Call Options Held

6.13M

Put Options Held

7.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Dexcom Inc Transaction History